CareLit · DOI-Nachweis · Aktuelle Rheumatologie
Treatment-Adjusted Cross-Sectional Associations of Serum Calprotectin, Sialic Acid, and Pannexin-1 with Interstitial Lung Disease in Treated Rheumatoid Arthritis
DOI 10.1055/a-2909-5126
Bibliografische Angaben
Nachweis in CareLit
Autor:innenBurcu Güneş Alpaydın, I. Merve Uçar Baytaroğlu, Gokhan Sargin, Ayça Tuzcu, Songül Çildağ, Taşkın Şentürk
ZeitschriftAktuelle Rheumatologie
Ausgabe09/2026
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Abstract Objective Most RA-ILD biomarker studies enroll patients receiving treatment, which may alter inflammatory activity. We investigated whether calprotectin, sialic acid, and pannexin-1 show treatment-adjusted cross-sectional associations with ILD status in patients receiving treatment for RA. Methods This cross-sectional case-control study included 154 participants (49 patients with HRCT-confirmed RA-ILD, 55 R…
Zitieren
Zitierempfehlung
Burcu Güneş Alpaydın, I. Merve Uçar Baytaroğlu, Gokhan Sargin, Ayça Tuzcu, Songül Çildağ, Taşkın Şentürk (2026) Treatment-Adjusted Cross-Sectional Associations of Serum Calprotectin, Sialic Acid, and Pannexin-1 with Interstitial Lung Disease in Treated Rheumatoid Arthritis. Aktuelle Rheumatologie (09). https://doi.org/10.1055/a-2909-5126
Mit CareLit weiterarbeiten